Kidney disease decisions — 2025

The Board denied an initial compensable disability rating for bilateral hearing loss and remanded the service connection claims for prostate cancer, kidney cancer, cervical spine disability, thoracolumbar spine disability, right hip disability, and left hip disability.

The Board remands the claim for service connection of chronic renal disease, to include stage 3 renal failure, due to a need for an addendum medical opinion.

The Board denied service connection for a heart condition and remanded claims for diabetes mellitus, renal kidney failure, colitis, and high blood pressure as secondary to diabetes mellitus.

The Board remands the case to obtain an opinion on whether the Veteran's kidney cancer is related to his service, including herbicide exposure.

The Board denied an initial rating in excess of 10 percent for hypertension and remanded the claims for service connection for bilateral hearing loss, tinnitus, chest injury, kidney disease, and a compensable rating for dermatophytosis due to pre-decisional failure of the duty to assist.

The Board denied service connection for a kidney disability and hypertension, as the evidence did not support a finding that these conditions were related to service or caused by any service-connected disabilities.

The Board granted service connection for chronic kidney disease (CKD) as secondary to the Veteran's service-connected hypertension, based on a favorable opinion from his treating nephrologist.

The appeal was dismissed due to the Veteran's death before filing an appeal to the Board.

The Board denied an increased rating for tinnitus and granted higher ratings for the low back disability, right and left lower extremity sciatic radiculopathy.

The Board granted service connection for urothelial cancer of the right renal pelvis and ureter, finding a nexus to in-service exposure to herbicide agents.

The Board remands the claims for service connection for kidney cancer and Parkinson's disease (ACE) to obtain additional medical opinions regarding the Veteran's toxic exposure risk activities.

The Board denied a rating in excess of 60 percent for chronic kidney disease as the Veteran's GFR readings did not meet the criteria for a higher rating.

The Board dismissed the appeal regarding the propriety of the rating reduction from 100 percent disabling to noncompensable for neoplasm of the kidney, left; small intestine metastatic cancer and hepatic cancer; and neoplasm of the bone (spine), as the February 2024 rating decision restored the 100 percent disability ratings.

The appeal for service connection for diabetes mellitus was withdrawn and dismissed, while the claim for a kidney disability is remanded for further development.

The Board granted a 10 percent rating for hypertension and service connection for chronic kidney disease as secondary to hypertension, while remanding other claims.

The appeal for service connection for chronic renal disease has been withdrawn by the Veteran.

The Board granted service connection for hypertension, finding that the Veteran's pre-existing condition was aggravated during his active-duty service. The claims for kidney stones and heart disease were remanded for further examination under the PACT Act.

The Board granted a 30 percent initial disability rating for service-connected kidney cancer and denied an increased rating greater than 30 percent. The claim for service connection for hypertension was remanded.

The Veteran was granted an initial 60 percent evaluation for renal cancer with partial nephrectomy and residuals of chronic kidney disease and voiding dysfunction.

The Board remands the claims for service connection for Conn's syndrome, GERD, and headaches to correct a duty to assist error that occurred prior to the January 2024 rating decision on appeal.